Search research articles
Contact Us
Filters
Showing results (191-200 of 237) with videos related to
Page
of 24
Sort By:
The Lancet. Oncology
|
May 12, 2019
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
Ignace Vergote, Giovanni Scambia, David M O'Malley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 20, 2021
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001
Christian Marth, Rafal Tarnawski, Alexandra Tyulyandina, et al.
Plos One
|
December 14, 2011
Genome-scale screen for DNA methylation-based detection markers for ovarian cancer
Mihaela Campan, Melissa Moffitt, Sahar Houshdaran, et al.
Gynecologic Oncology
|
May 19, 2026
A review of reviews of the prevalence of molecular biomarkers in vulvar cancer and their implications for prognosis refinement and treatment strategies
Rita Trozzi, Gloria Anderson, Viviana Romano, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 21, 2016
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery
Denis Querleu, François Planchamp, Luis Chiva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 25, 2013
Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study
Ignace B Vergote, Antonio Jimeno, Florence Joly, et al.
Cancer
|
June 17, 2022
Real-life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (RESPONSE trial)
Christian Marth, Miguel Henriques Abreu, Klaus Kaae Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2024
Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective Study
Christine Brunner, Marjan Arvandi, Christian Marth, et al.
The New England Journal of Medicine
|
August 27, 2005
A pooled analysis of bone marrow micrometastasis in breast cancer
Stephan Braun, Florian D Vogl, Bjørn Naume, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 6, 2011
Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer
Jonathan A Ledermann, Christian Marth, Mark S Carey, et al.
Page
of 24
Search research articles
Search
Showing results (191-200 of 237) with videos related to
Sort By:
Page
of 24
The Lancet. Oncology
|
May 12, 2019
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
Ignace Vergote, Giovanni Scambia, David M O'Malley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 20, 2021
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001
Christian Marth, Rafal Tarnawski, Alexandra Tyulyandina, et al.
Plos One
|
December 14, 2011
Genome-scale screen for DNA methylation-based detection markers for ovarian cancer
Mihaela Campan, Melissa Moffitt, Sahar Houshdaran, et al.
Gynecologic Oncology
|
May 19, 2026
A review of reviews of the prevalence of molecular biomarkers in vulvar cancer and their implications for prognosis refinement and treatment strategies
Rita Trozzi, Gloria Anderson, Viviana Romano, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 21, 2016
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery
Denis Querleu, François Planchamp, Luis Chiva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 25, 2013
Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study
Ignace B Vergote, Antonio Jimeno, Florence Joly, et al.
Cancer
|
June 17, 2022
Real-life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (RESPONSE trial)
Christian Marth, Miguel Henriques Abreu, Klaus Kaae Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2024
Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective Study
Christine Brunner, Marjan Arvandi, Christian Marth, et al.
The New England Journal of Medicine
|
August 27, 2005
A pooled analysis of bone marrow micrometastasis in breast cancer
Stephan Braun, Florian D Vogl, Bjørn Naume, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 6, 2011
Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer
Jonathan A Ledermann, Christian Marth, Mark S Carey, et al.
Page
of 24